Clinical Trial Update: Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma

View source ↗

Summary

This completed clinical trial evaluated the activity of PD-1 inhibitors in metastatic uveal melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Snippet

Sponsor: Institut Curie | Conditions: Uveal Melanoma | Status: COMPLETED